Processing

Please wait...

Settings

Settings

Goto Application

1. WO2012136309 - MELANOCYTE-STIMULATION HORMONE FOR SUPPRESSING INFLAMMATION REACTIONS IN HEMODIALYSIS

Publication Number WO/2012/136309
Publication Date 11.10.2012
International Application No. PCT/EP2012/001190
International Filing Date 17.03.2012
IPC
A61K 38/34 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
33derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
34Melanocyte stimulating hormone , e.g. alpha- or beta-melanotropin
A61P 13/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
12of the kidneys
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61K 47/48 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
48the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
A61M 1/16 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
1Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
14Dialysis systems; Artificial kidneys; Blood oxygenators
16with membranes
CPC
A61K 38/34
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
33derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
34Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
A61K 47/50
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K 47/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
56the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
59obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
60the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
A61K 47/6957
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
69the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
6957the form being a device or a kit, e.g. stents or microdevices
A61M 1/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
1Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
14Dialysis systems; Artificial kidneys; Blood oxygenators; ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
16with membranes
A61M 1/3679
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
1Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; ; Extra-corporeal blood circuits
3679by absorption
Applicants
  • FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH [DE]/[DE] (AllExceptUS)
  • PASSLICK-DEET JEN, Jutta [DE]/[DE] (UsOnly)
  • FISLAGE, Rainer [DE]/[DE] (UsOnly)
  • KUHN, Anja [DE]/[DE] (UsOnly)
  • STEPPAN, Sonja [DE]/[DE] (UsOnly)
Inventors
  • PASSLICK-DEET JEN, Jutta
  • FISLAGE, Rainer
  • KUHN, Anja
  • STEPPAN, Sonja
Agents
  • WEIβ, Stefan
Priority Data
11002918.807.04.2011EP
61/457,47807.04.2011US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MELANOCYTE-STIMULATION HORMONE FOR SUPPRESSING INFLAMMATION REACTIONS IN HEMODIALYSIS
(FR) HORMONE DE STIMULATION DU MÉLANOCYTE DESTINÉE À SUPPRIMER LES RÉACTIONS D'INFLAMMATION DANS UNE HÉMODIALYSE
Abstract
(EN)
The invention relates to a construct S-L-aMSH comprising a surface S of a solid support, a linker L and melanocyte-stimulation hormone aMSH, wherein aMSH is immobilized on the surface S through the linker L for the use in dialysis treatment, preferably hemodialysis treatment.
(FR)
La présente invention concerne une construction S-L-aMSH comprenant une surface S d'un support solide, un lieur L et une hormone de stimulation du mélanocyte aMSH, l'aMSH étant immobilisée sur la surface S par le lieur L, pour permettre une utilisation dans un traitement par dialyse, de préférence un traitement par hémodialyse.
Also published as
Latest bibliographic data on file with the International Bureau